Earth Science Tech (ETST) EBIT Growth (3y) (2014 - 2026)
Earth Science Tech (ETST) EBIT Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 273.62% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 3.84% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -59.82% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 4.63% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -30.05% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 54.58% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 40.17% |
| 10 | Earth Science Tech | 32.24 Mn | 30.08 Mn | 6.27 Mn | 126.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 126.20% |
| Dec 31, 2025 | 210.03% |
| Sep 30, 2025 | 112.35% |
| Jun 30, 2025 | 32.93% |
| Mar 31, 2025 | 178.11% |
| Dec 31, 2024 | 61.87% |
| Sep 30, 2024 | 171.26% |
| Jun 30, 2024 | 355.12% |
| Mar 31, 2024 | 49.75% |
| Dec 31, 2023 | 69.11% |
| Sep 30, 2023 | 28.44% |
| Jun 30, 2023 | 81.90% |
| Mar 31, 2023 | 3.31% |
| Dec 31, 2022 | 37.41% |
| Sep 30, 2022 | 31.33% |
| Jun 30, 2022 | -26.48% |
| Mar 31, 2022 | 48.34% |
| Dec 31, 2021 | 42.10% |
| Sep 30, 2021 | 57.65% |
| Jun 30, 2021 | 71.86% |